This has been confirmed by detecting reduced protein and mRNA expression levels of COL1A1 and α-SMA and downregulation of serum ALT/AST levels in activated HSC-T6 cells and primary HSCs isolated from a liver fibrosis mouse model. This evidence concerns the gene COL1A1 and Hepatic fibrosis.